Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$27,345,711
+$1,810,531 QoQ
Shares Held
107,673
+3.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.92%
of 13F equity value
Holder Rank
#623
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bryn Mawr Trust Advisors, LLC holds $73,679,493 across 10 Drug Manufacturers - General names. JNJ ranks #2 (37.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
220,148 | $28,289,018 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
107,673 | $27,345,711 | |
| 3 | AZN |
Astrazeneca PLC
|
27,799 | $5,271,246 | |
| 4 | LLY |
ELI LILLY & Co
|
3,407 | $4,086,458 | |
| 5 | AMGN |
Amgen Inc
|
9,560 | $3,461,867 | |
| 6 | ABBV |
AbbVie Inc.
|
8,879 | $2,234,311 | |
| 7 | PFE |
Pfizer Inc
|
49,991 | $1,203,783 | |
| 8 | NVS |
Novartis AG
|
5,909 | $926,058 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,345,711 | 107,673 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $25,535,180 | 104,464 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $22,905,019 | 110,679 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $20,827,486 | 112,326 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $17,343,082 | 113,539 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $19,024,501 | 114,716 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $18,661,475 | 129,038 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $21,449,289 | 132,354 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $19,362,546 | 132,475 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $19,730,722 | 124,728 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $20,919,460 | 133,466 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $22,931,072 | 147,230 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,302,080 | 44,116 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,149,065 | 46,123 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $8,252,204 | 46,715 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,441,995 | 21,070 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,755,046 | 21,154 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,879,564 | 21,890 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,513,456 | 8,847 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,386,477 | 8,585 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,620,382 | 9,836 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,442,006 | 8,774 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,352,523 | 8,594 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,234,810 | 8,294 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,172,572 | 8,338 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,108,704 | 8,455 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||